rais believ grow competit pressur
close post top bottom line beat manag rais
revenu guidanc low high-end long-term target
invisalign revenu volum also grow low though notic bump
given manag histor conserv stanc clear momentum busi
would surpris see upsid believ intern
continu outperform becom bigger piec mix outgrow
competit runway growth get better price ou
like invest heavili year support growth may pressur margin
though sg contain quarter given recent pullback clearli strong
momentum busi go along increas guidanc encourag
investor buy share despit premium valuat
quarterli result close report sale
growth beat target impress driven
strong clear align revenu almost intern howev addit much
stronger expect scanner revenu grew y/i intern case
growth slightli model broad base
emea apac off-set intenational drove intenational
revenu model na case volum increas
y/i grew drove na align revenu
beat slightli even market spend align demonstr
cost control gross margin exceed estim oper
margin exceed bogey come lower
model bottom line post ep beat estim
manag issu case guidanc came
ahead street estim midpoint revenu standpoint
compani expect around street midpoint
gm opex tax rate ep expect
street
what import call report near perfect quarter
revenu beat rais found three key point call first
manag rais revenu guidanc low high-
end long-term target expect invisalign revenu
volum also grow low clearli invest market correl well
increas sale growth dynam anticip continu come
quarter would also note expect op margin flat slightli
increment stronger last quarter call metric
flat y/i continu follow page
competit patent expir failur innov product adopt
align design manufactur system clear align therapi
price close april
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
import even though guidanc notic jump previou model given
manag histor conserv stanc toward target clearli acceler
momentum busi would surpris addit upsid number
year second key point quarter view out-performance itero scanner
revenu yoy continu believ posit catalyst increas invisalign
util evid momentum solid clinician buy scanner increas clip
impli us doc interest invest build
invisalign practic also encourag today announc approv china
market compani
third final expect impact potenti upcom competit address
manag continu believ multipl player lift overal adopt
categori though may potenti lose share lower end market
intern continu outperform grow bigger piec revenu mix
come quarter year believ competit less issu get better
price ou long runway growth mani larg under-penetrated market
continu view increas y/i quarter posit indic ahead potenti
futur competit product launch doubt custom would will accept higher
price knew similar product horizon see market doc
train initi make intern begin pay believ oper
invest could provid strong augment growth profil busi come
quarter year
stock bearish view competit premium valuat
surpris see stock sell print said continu view
one differenti name med tech continu believ
long way go overal align market compani benefit
dynam given recent pullback name strong momentum busi go
along increas guidanc encourag investor buy share despit premium
valuat maintain pt base updat
ep estim given rerat stock increas ep
page
sourc compani report piper jaffray co estim
page
y/yactual-estimatenet gener net incom tax net incom analysi gross gener analysi north america align align analysi north america align align analysi north american inc
thousand except per share data
revenu
equiti loss investe net tax
good sold
percent sale
revenu
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
